Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.

Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
复制标题

Smek1 缺陷通过激活促炎小胶质细胞和抑制 IDO1-AhR 通路加剧实验性自身免疫性脑脊髓炎

DOI:
10.1186/s12974-021-02193-0
复制
发表时间:
2021-06-28
影响因子:
9.3
通讯作者:
Liu QJ
Liu QJ
中科院分区:
医学1区
文献类型:
--
作者:
Duan RN;Yang CL;Du T;Liu A;Wang AR;Sun WJ;Li X;Li JX;Yan CZ;Liu QJ

文献摘要

参考文献

被引文献

相似文献

Experimental autoimmune encephalomyelitis (EAE) is an animal disease model of multiple sclerosis (MS) that involves the immune system and central nervous system (CNS). However, it is unclear how genetic predispositions promote neuroinflammation in MS and EAE. Here, we investigated how partial loss-of-function of suppressor of MEK1 (SMEK1), a regulatory subunit of protein phosphatase 4, facilitates the onset of MS and EAE. C57BL/6 mice were immunized with myelin oligodendrocyte glycoprotein 35-55 (MOG35-55) to establish the EAE model. Clinical signs were recorded and pathogenesis was investigated after immunization. CNS tissues were analyzed by immunostaining, quantitative polymerase chain reaction (qPCR), western blot analysis, and enzyme-linked immunosorbent assay (ELISA). Single-cell analysis was carried out in the cortices and hippocampus. Splenic and lymph node cells were evaluated with flow cytometry, qPCR, and western blot analysis. Here, we showed that partial Smek1 deficiency caused more severe symptoms in the EAE model than in controls by activating myeloid cells and that Smek1 was required for maintaining immunosuppressive function by modulating the indoleamine 2,3-dioxygenase (IDO1)-aryl hydrocarbon receptor (AhR) pathway. Single-cell sequencing and an in vitro study showed that Smek1-deficient microglia and macrophages were preactivated at steady state. After MOG35-55 immunization, microglia and macrophages underwent hyperactivation and produced increased IL-1β in Smek1-/+ mice at the peak stage. Moreover, dysfunction of the IDO1-AhR pathway resulted from the reduction of interferon γ (IFN-γ), enhanced antigen presentation ability, and inhibition of anti-inflammatory processes in Smek1-/+ EAE mice. The present study suggests a protective role of Smek1 in autoimmune demyelination pathogenesis via immune suppression and inflammation regulation in both the immune system and the central nervous system. Our findings provide an instructive basis for the roles of Smek1 in EAE and broaden the understanding of the genetic factors involved in the pathogenesis of autoimmune demyelination. The online version contains supplementary material available at 10.1186/s12974-021-02193-0.
DOI: 10.1128/jvi.78.5.2632-2636.2004
发表时间: 2004-03-01
影响因子: 5.4
作者:
Adams, O;Besken, K;Däubener, W
通讯作者: Däubener, W
DOI: 10.4049/jimmunol.164.7.3596
发表时间: 2000-04-01
影响因子: 4.4
作者:
Hwu, P;Du, MX;Young, HA
通讯作者: Young, HA
DOI: 10.1016/s0925-4773(03)00099-6
发表时间: 2002-12-01
影响因子: 2.6
作者:
Hayashi, Shigemi;Lewis, Paula;McMahon, Andrew P.
通讯作者: McMahon, Andrew P.
DOI: 10.1186/s12974-016-0757-6
发表时间: 2016-11-15
影响因子: 9.3
作者:
Borjini N;Fernández M;Giardino L;Calzà L
通讯作者: Calzà L
DOI: 10.1128/mbio.01675-19
发表时间: 2019-07-01
期刊: MBIO
影响因子: 6.4
作者:
Bonney, Stephanie;Seitz, Scott;Siegenthaler, Julie A.
通讯作者: Siegenthaler, Julie A.